{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:03:44Z","timestamp":1761563024582},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,10]]},"DOI":"10.7759\/cureus.52017","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T14:11:58Z","timestamp":1704895918000},"source":"Crossref","is-referenced-by-count":1,"title":["T-cell Acute Lymphoblastic Leukemia in Crisis: Hyperleukocytosis, Tumor Lysis Syndrome, and Innovative Approaches"],"prefix":"10.7759","author":[{"given":"Gordon","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariel","family":"Duchow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levy","family":"Amar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-07-692608","article-title":"Management of adults with T-cell lymphoblastic leukemia","volume":"129","author":"Marks DI","year":"2017","unstructured":"Marks DI, Rowntree C. Management of adults with T-cell lymphoblastic leukemia. Blood. 2017, 129:1134-42. 10.1182\/blood-2016-07-692608","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-347872","article-title":"Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007","volume":"119","author":"Dores GM","year":"2012","unstructured":"Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood. 2012, 119:34-43. 10.1182\/blood-2011-04-347872","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02192-z","article-title":"The evolution of relapse of adult T cell acute lymphoblastic leukemia","volume":"21","author":"Sent\u00eds I","year":"2020","unstructured":"Sent\u00eds I, Gonzalez S, Genesc\u00e0 E, et al.. The evolution of relapse of adult T cell acute lymphoblastic leukemia. Genome Biol. 2020, 21:284. 10.1186\/s13059-020-02192-z","journal-title":"Genome Biol"},{"key":"ref4","article-title":"Acute Lymphocytic Leukemia","author":"Puckett Y","year":"2023","unstructured":"Puckett Y, Chan O. Acute Lymphocytic Leukemia. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85918-8","article-title":"The factors influencing clinical outcomes after leukapheresis in acute leukaemia","volume":"11","author":"Lee H","year":"2021","unstructured":"Lee H, Park S, Yoon JH, et al.. The factors influencing clinical outcomes after leukapheresis in acute leukaemia. Sci Rep. 2021, 11:6426. 10.1038\/s41598-021-85918-8","journal-title":"Sci Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V104.11.1963.1963","article-title":"Complications of hyperleukocytosis and leukapheresis in pediatric acute leukemias","volume":"104","author":"Abla O","year":"2004","unstructured":"Abla O, Khanani MF, Hitzler JK, et al.. Complications of hyperleukocytosis and leukapheresis in pediatric acute leukemias. Blood. 2004, 104:1963. 10.1182\/blood.V104.11.1963.1963","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/BF00321058","article-title":"Leucostasis, an underestimated cause of death in leukaemia","volume":"56","author":"van Buchem MA","year":"1988","unstructured":"van Buchem MA, te Velde J, Willemze R, Spaander PJ. Leucostasis, an underestimated cause of death in leukaemia. Blut. 1988, 56:39-44. 10.1007\/BF00321058","journal-title":"Blut"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.9.1364","article-title":"Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival","volume":"5","author":"Dutcher JP","year":"1987","unstructured":"Dutcher JP, Schiffer CA, Wiernik PH. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol. 1987, 5:1364-72. 10.1200\/JCO.1987.5.9.1364","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01406.x","article-title":"Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis","volume":"47","author":"Bug G","year":"2007","unstructured":"Bug G, Anargyrou K, Tonn T, Bialleck H, Seifried E, Hoelzer D, Ottmann OG. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis. Transfusion. 2007, 47:1843-50. 10.1111\/j.1537-2995.2007.01406.x","journal-title":"Transfusion"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1977.03630210112032","article-title":"Hydroxyurea in the prevention of the effects of leukostasis in acute leukemia","volume":"137","author":"Grund FM","year":"1977","unstructured":"Grund FM, Armitage JO, Burns P. Hydroxyurea in the prevention of the effects of leukostasis in acute leukemia. Arch Intern Med. 1977, 137:1246-7. 10.1001\/archinte.1977.03630210112032","journal-title":"Arch Intern Med"},{"key":"ref11","article-title":"Tumor Lysis Syndrome","author":"Adeyinka A","year":"2022","unstructured":"Adeyinka A, Bashir K. Tumor Lysis Syndrome. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2022."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue","volume":"34","author":"Padmanabhan A","year":"2019","unstructured":"Padmanabhan A, Connelly-Smith L, Aqui N, et al.. Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue. J Clin Apher. 2019, 34:171-354. 10.1002\/jca.21705","journal-title":"J Clin Apher"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15994","article-title":"Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-a systematic review and meta-analysis","volume":"60","author":"Bewersdorf JP","year":"2020","unstructured":"Bewersdorf JP, Giri S, Tallman MS, Zeidan AM, Stahl M. Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-a systematic review and meta-analysis. Transfusion. 2020, 60:2360-9. 10.1111\/trf.15994","journal-title":"Transfusion"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0783-3","article-title":"Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study","volume":"34","author":"Stahl M","year":"2020","unstructured":"Stahl M, Shallis RM, Wei W, et al.. Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study. Leukemia. 2020, 34:3149-60. 10.1038\/s41375-020-0783-3","journal-title":"Leukemia"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.1943011.x","article-title":"Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate","volume":"98","author":"Porcu P","year":"1997","unstructured":"Porcu P, Danielson CF, Orazi A, Heerema NA, Gabig TG, McCarthy LJ. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate. Br J Haematol. 1997, 98:433-6. 10.1046\/j.1365-2141.1997.1943011.x","journal-title":"Br J Haematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S312140","article-title":"Leukapheresis does not improve early survival outcome of acute myeloid leukemia with leukostasis patients - a dual-center retrospective cohort study","volume":"12","author":"Rinaldi I","year":"2021","unstructured":"Rinaldi I, Sari RM, Tedhy VU, Winston K. Leukapheresis does not improve early survival outcome of acute myeloid leukemia with leukostasis patients - a dual-center retrospective cohort study. J Blood Med. 2021, 12:623-33. 10.2147\/JBM.S312140","journal-title":"J Blood Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2020.1751609","article-title":"Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits","volume":"13","author":"Shallis RM","year":"2020","unstructured":"Shallis RM, Stahl M, Bewersdorf JP, Hendrickson JE, Zeidan AM. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits. Expert Rev Hematol. 2020, 13:489-99. 10.1080\/17474086.2020.1751609","journal-title":"Expert Rev Hematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13146","article-title":"A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis","volume":"168","author":"Kuo KH","year":"2015","unstructured":"Kuo KH, Callum JL, Panzarella T, et al.. A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis. Br J Haematol. 2015, 168:384-94. 10.1111\/bjh.13146","journal-title":"Br J Haematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1159\/000534453","article-title":"Tumor lysis syndrome is associated with worse outcomes in adult patients with acute lymphoblastic leukemia","author":"Rios-Olais FA","year":"2023","unstructured":"Rios-Olais FA, Gil-Lopez F, Mora-Ca\u00f1as A, Demichelis-G\u00f3mez R. Tumor lysis syndrome is associated with worse outcomes in adult patients with acute lymphoblastic leukemia. Acta Haematol. 2023, 10.1159\/000534453","journal-title":"Acta Haematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1159\/000341805","article-title":"Leukocyte depletion by therapeutic leukocytapheresis in patients with leukemia","volume":"39","author":"H\u00f6lig K","year":"2012","unstructured":"H\u00f6lig K, Moog R. Leukocyte depletion by therapeutic leukocytapheresis in patients with leukemia. Transfus Med Hemother. 2012, 39:241-5. 10.1159\/000341805","journal-title":"Transfus Med Hemother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/220826-t-cell-acute-lymphoblastic-leukemia-in-crisis-hyperleukocytosis-tumor-lysis-syndrome-and-innovative-approaches","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:11Z","timestamp":1707509471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/220826-t-cell-acute-lymphoblastic-leukemia-in-crisis-hyperleukocytosis-tumor-lysis-syndrome-and-innovative-approaches"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.52017","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,10]]}}}